Research ArticleCARDIOVASCULAR
Pharmacologic Characterization of BMS-191095, a Mitochondrial KATP Opener with No Peripheral Vasodilator or Cardiac Action Potential Shortening Activity
Gary J. Grover, Albert J. D'Alonzo, Keith D. Garlid, Robert Bajgar, Nicholas J. Lodge, Paul G. Sleph, Raymond B. Darbenzio, Thomas A. Hess, Mark A. Smith, Petr Paucek and Karnail S. Atwal
Journal of Pharmacology and Experimental Therapeutics June 2001, 297 (3) 1184-1192;
Gary J. Grover
Albert J. D'Alonzo
Keith D. Garlid
Robert Bajgar
Nicholas J. Lodge
Paul G. Sleph
Raymond B. Darbenzio
Thomas A. Hess
Mark A. Smith
Petr Paucek
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 297, Issue 3
1 Jun 2001
Research ArticleCARDIOVASCULAR
Pharmacologic Characterization of BMS-191095, a Mitochondrial KATP Opener with No Peripheral Vasodilator or Cardiac Action Potential Shortening Activity
Gary J. Grover, Albert J. D'Alonzo, Keith D. Garlid, Robert Bajgar, Nicholas J. Lodge, Paul G. Sleph, Raymond B. Darbenzio, Thomas A. Hess, Mark A. Smith, Petr Paucek and Karnail S. Atwal
Journal of Pharmacology and Experimental Therapeutics June 1, 2001, 297 (3) 1184-1192;
Research ArticleCARDIOVASCULAR
Pharmacologic Characterization of BMS-191095, a Mitochondrial KATP Opener with No Peripheral Vasodilator or Cardiac Action Potential Shortening Activity
Gary J. Grover, Albert J. D'Alonzo, Keith D. Garlid, Robert Bajgar, Nicholas J. Lodge, Paul G. Sleph, Raymond B. Darbenzio, Thomas A. Hess, Mark A. Smith, Petr Paucek and Karnail S. Atwal
Journal of Pharmacology and Experimental Therapeutics June 1, 2001, 297 (3) 1184-1192;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement